Martine Wettendorff

1.8k total citations
24 papers, 1.4k citations indexed

About

Martine Wettendorff is a scholar working on Immunology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Martine Wettendorff has authored 24 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 12 papers in Epidemiology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Martine Wettendorff's work include Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Hepatitis B Virus Studies (7 papers). Martine Wettendorff is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Hepatitis B Virus Studies (7 papers). Martine Wettendorff collaborates with scholars based in Belgium, United States and Switzerland. Martine Wettendorff's co-authors include Nathalie Garçon, Marcelle Van Mechelen, Pierre Vandepapelière, Geert Leroux‐Roels, Dorothee Herlyn, Emmanuel Hanon, Yves Horsmans, Dimitrios Iliopoulos, Sally Mossman and Philippe Moris and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and The Journal of Infectious Diseases.

In The Last Decade

Martine Wettendorff

24 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martine Wettendorff Belgium 16 785 666 287 218 196 24 1.4k
Frances J. Palmer‐Hill United States 8 878 1.1× 366 0.5× 325 1.1× 67 0.3× 217 1.1× 8 1.3k
Syed M. Moin United States 19 977 1.2× 467 0.7× 359 1.3× 153 0.7× 586 3.0× 22 1.6k
Nadia L. Bernasconi United States 9 721 0.9× 1.5k 2.3× 252 0.9× 212 1.0× 305 1.6× 9 2.3k
Theresa Flynn United States 12 412 0.5× 807 1.2× 196 0.7× 162 0.7× 509 2.6× 15 1.6k
J. W. Gnann United States 16 984 1.3× 311 0.5× 183 0.6× 159 0.7× 326 1.7× 21 1.5k
Daniel C. Freed United States 25 1.0k 1.3× 914 1.4× 361 1.3× 118 0.5× 425 2.2× 47 2.0k
Sylvie Corbet Denmark 17 414 0.5× 536 0.8× 429 1.5× 237 1.1× 281 1.4× 34 1.2k
Joshua A. Horwitz United States 18 603 0.8× 760 1.1× 315 1.1× 354 1.6× 561 2.9× 23 1.9k
Chantal Tougne Switzerland 21 427 0.5× 1.0k 1.5× 305 1.1× 153 0.7× 196 1.0× 31 1.7k
Steve McAdam United Kingdom 16 512 0.7× 1.3k 1.9× 271 0.9× 87 0.4× 367 1.9× 23 2.0k

Countries citing papers authored by Martine Wettendorff

Since Specialization
Citations

This map shows the geographic impact of Martine Wettendorff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine Wettendorff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine Wettendorff more than expected).

Fields of papers citing papers by Martine Wettendorff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine Wettendorff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine Wettendorff. The network helps show where Martine Wettendorff may publish in the future.

Co-authorship network of co-authors of Martine Wettendorff

This figure shows the co-authorship network connecting the top 25 collaborators of Martine Wettendorff. A scholar is included among the top collaborators of Martine Wettendorff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine Wettendorff. Martine Wettendorff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stoffel, M., et al.. (2021). Addressing vaccine supply challenges in Europe: Expert industry perspective and recommendations. Health Policy. 126(1). 35–42. 3 indexed citations
2.
3.
Most, Robbert van der, François Roman, Bruce L. Innis, et al.. (2014). Seeking Help: B Cells Adapting to Flu Variability. Science Translational Medicine. 6(246). 246ps8–246ps8. 16 indexed citations
4.
Most, Robbert van der, Marcelle Van Mechelen, Éric Destexhe, Martine Wettendorff, & Emmanuel Hanon. (2013). Narcolepsy and A(H1N1)pdm09 vaccination. Human Vaccines & Immunotherapeutics. 10(3). 572–576. 11 indexed citations
5.
Schleiss, Mark R., K. Yeon Choi, Jodi Anderson, et al.. (2013). Glycoprotein B (gB) vaccines adjuvanted with AS01 or AS02 protect female guinea pigs against cytomegalovirus (CMV) viremia and offspring mortality in a CMV-challenge model. Vaccine. 32(23). 2756–2762. 40 indexed citations
6.
Garçon, Nathalie, Sandra Morel, Arnaud M. Didierlaurent, et al.. (2011). Development of an AS04-Adjuvanted HPV Vaccine with the Adjuvant System Approach. BioDrugs. 25(4). 217–226. 90 indexed citations
7.
Garçon, Nathalie, Martine Wettendorff, & Marcelle Van Mechelen. (2011). Role of AS04 in human papillomavirus vaccine: mode of action and clinical profile. Expert Opinion on Biological Therapy. 11(5). 667–677. 43 indexed citations
8.
Baras, Benoı̂t, Koert J. Stittelaar, James H. Simon, et al.. (2008). Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine. PLoS ONE. 3(1). e1401–e1401. 142 indexed citations
9.
10.
Vandepapelière, Pierre, Yves Horsmans, Philippe Moris, et al.. (2008). Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine. 26(10). 1375–1386. 168 indexed citations
11.
12.
Vandepapelière, Pierre, R Barrasso, Chris J.L.M. Meijer, et al.. (2005). Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination. The Journal of Infectious Diseases. 192(12). 2099–2107. 97 indexed citations
13.
Vandepapelière, Pierre, Barbara Rehermann, Marguerite Koutsoukos, et al.. (2004). Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults. Vaccine. 23(20). 2591–2601. 38 indexed citations
14.
Jacques, P, Guido Moens, Isabelle Desombere, et al.. (2002). The immunogenicity and reactogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine. 20(31-32). 3644–3649. 66 indexed citations
15.
Wettendorff, Martine. (2001). Therapeutic Vaccination. Virus Research. 82(1-2). 133–140. 3 indexed citations
16.
Wettendorff, Martine, Catherine Massacrier, Béatrice Vanbervliet, et al.. (1995). Activation of Primary Allogeneic CD8+ T Cells by Dendritic Cells Generated in Vitro from CD34+ Cord Blood Progenitor Cells. Advances in experimental medicine and biology. 378. 371–374. 6 indexed citations
17.
Barcy, Serge, Martine Wettendorff, Oberdan Léo, et al.. (1995). FcR cross-linking on monocytes results in impaired T cell stimulatory capacity. International Immunology. 7(2). 179–189. 43 indexed citations
18.
Herlyn, Dorothee, et al.. (1989). Modulation of Cancer Patients' Immune Responses by Administration of Anti-Idiotypic Antibodies. Viral Immunology. 2(4). 271–276. 6 indexed citations
19.
Wettendorff, Martine, et al.. (1989). Specific detection of antibodies in cancer patients following immunotherapy with anti-idiotype. Journal of Immunological Methods. 116(1). 105–115. 13 indexed citations
20.
Herlyn, Dorothee, Martine Wettendorff, & Hilary Koprowski. (1989). Modulation of Cancer Patients' Immune Responses by Anti-idiotypic Antibodies. International Reviews of Immunology. 4(4). 347–357. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Frances J. Palmer‐Hill Breakdown of academic impact, for papers by Syed M. Moin Breakdown of academic impact, for papers by Nadia L. Bernasconi Breakdown of academic impact, for papers by Theresa Flynn Breakdown of academic impact, for papers by J. W. Gnann Breakdown of academic impact, for papers by Daniel C. Freed Breakdown of academic impact, for papers by Sylvie Corbet Breakdown of academic impact, for papers by Joshua A. Horwitz Breakdown of academic impact, for papers by Chantal Tougne Breakdown of academic impact, for papers by Steve McAdam
Rankless by CCL
2026